ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Tobacco Industry Walkout Unlikely To Imperil Legislation

April 17, 1998

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Straus asks to “Set Record Straight”

September 2, 1988

Love, Avon Foundations Recruit Women For Research.

October 3, 2008

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981